Evaluation of coagulation factor abnormalities in long-acting anticoagulant overdose

References

• Barlow A. M., Gay A. L., Park B. K. Difenacoum (neosorexa) poisoning. Br. Med. J. 1982; 285: 541
   PubMed Web of Science ®Google Scholar
• Chong L., Chau W., Ho C. A Case of “superwarfarin” rodenticide poisoning. Scan. J. Hem. 1986; 35: 314–315
   Google Scholar
• Lipton R. A., Klass E. M. Human ingestion of a “superwarfarin” rodenticide resulting in a prolonged anticoagulant effect. J.A.M.A. 1984; 252: 3004–3005
   PubMed Web of Science ®Google Scholar
• Jones E. C., Gershon G. H., Sheldon N. C. Prolonged anticoagulation in rat poisoning. J.A.M.A. 1984; 252: 3005–3006
   PubMed Web of Science ®Google Scholar
• Murdoch D. A. Prolonged anticoagulation in chlorphacinone poisoning. Lancet 1983; 1: 355–356
   PubMed Web of Science ®Google Scholar
• Lackner H., Hunt V., Zucker M. B. Abnormal fibrin ultrasructure, polymerization, and clot retraction in multiple myeloma. Br. J. Haematol 1970; 18: 625–636
   PubMed Web of Science ®Google Scholar
• Ellis B. C., Stransky A. A quick and accurate method for the determination of fibrinogen in plasma. J. Lab. Clin. Med. 1961; 58: 477–488
   PubMedGoogle Scholar
• Pechet L. One-stage specific determination of factor II (prothrombin). Blood coagulation, hemorrhage and thrombosis, L. M. Tocantins, L. A. Kazal. Grune and Stratton, New York 1964; 144–148
   Google Scholar
• Shanberge J. N., Matsouka T., Fukui H. A simple method for the preparation of a substrate for a one-stage factor V assay. Am. J. Clin. Pathol. 1967; 47: 533–537
   Web of Science ®Google Scholar
• Adamis D., Sise H. S., Kimball D. M. The proconvertin test: a simplified method and its application to the study of anticoagulant processes. J. Lab. Clin. Med. 1956; 47: 320–325
   PubMedGoogle Scholar
• Nossell H. L. The contact phase of blood coagulation. F.A. Davis Co., Philadelphia 1964; 124
   Google Scholar
• Denson K. W. The specific assay of Prower-Stuart factor and factor VII. Acta Heamatol. 1961; 25: 105–120
   PubMed Web of Science ®Google Scholar
• Newman J., Johnson A. J., Karpatkin M. H. Methods for the production of clinically effective intermediate- and high-purity factor-VIII concentrates. Br. J. Haematol. 1971; 21: 1–20
   PubMed Web of Science ®Google Scholar
• Flomenbaum N. Anticoagulants. Poisondex, B. H. Rumak. Micromedex, Denver 1987; 54
   Google Scholar
• Lund M. Comparative effect of the three rodenticides warfarin, difenacoum, and brodifacoum on eight rodent species in short feeding periods. J. Hyq. 1981; 87: 101–107
   Google Scholar
• Park B. K., Leck J. B. A comparison of Vitamin K antagonism by warfarin, difenacoum, and brodifacoum in the rabbit. Biochem. Pharmacol. 1982; 31: 3635–3639
   PubMed Web of Science ®Google Scholar
• Leck J. B., Park B. K. A comparative study of the effect of warfarin and brodifacoum on the relationship between Vitamin Kl metabolism and clotting factor activity in warfarin-susceptible and warfarin-resistant rats. Biochem. Pharmacol. 1981; 30: 123–128
   PubMed Web of Science ®Google Scholar
• Rosenberg R. D. Hemorrhagic disorders I. Protein interactions in the clotting mechanism. Hematology, W. S. Beck. The M.I.T. Press, Cambridge 1979; 9485–569
   Google Scholar
• Choonara B. A., Scott A. K., Haynes B. P., Cholerton S., Breckenridge A. M., Park B. K. Vitamin Kl metabolism in relation to pharmacodynamic response in anticaogulated patients. Br. J. Clin. Parmac. 1985; 20: 643–648
   PubMed Web of Science ®Google Scholar
• Olson R., Vitamin K. Hemostasis and thrombosis, R. W. Colman, J. Hirsh, V. J. Marder, E. W. Salzman. J.B. Lippincott Co., Philadelphia 1987; 846–860
   Google Scholar
• Wessler S., Gitel S. N. Warfarin. N. Eng. J. Med. 1984; 314: 645–652
   Google Scholar
• Wallin R., Martin L. F. Vitamin K-dependent carboxylation and vitamin K metabolism in the liver. J. Clin. Invest. 1985; 76: 1879–1884
   PubMed Web of Science ®Google Scholar
• O'Reilly R. A. Vitamin K antagonists. Hemostasis and thrombosis, R. W. Colman, J. Hirsh, V. J. Marder, E. W. Salzman. J.B. Lippincott Co., Philadelphia 1987; 846–860
   Google Scholar
• Park B. K., Scott A. K., Wilson A. C., Haynes B. P., Breckenridge A. M. Plasma disposition of vitamin Kl in relationship to anticoagulant posioning. Br. J. Clin. Pharmac. 1984; 18: 655–661
   PubMed Web of Science ®Google Scholar
• Braithwaite G. B. Vitamin K and brodifacoum. J. Am. Vet. Med. Assoc. 1982; 181: 531–534
   PubMed Web of Science ®Google Scholar
• Brechenridge A. M., Leck J. B., Serlin M. J., Wilson A. Mechanisms of action of the anticoagulants warfarin, 2-chloro-3-phytylnaphthoquinone (CL-K) acenocoumerol, brodifacoum and difenacoum in the rabbit. Proc. of the B.P.S. September, 1978; 339
   Google Scholar
• Bachmann K. A., Sullivan T. J. Dispositional and pharmacodynamic characteristics of brodifacoum in warfarin-sensitive rats. Pharmacology 1983; 27: 281–288
   PubMed Web of Science ®Google Scholar
• Smolinske S. C., Scherger D. S., Kearns P. S., Rumak B. H. Long-acting anticoagulant rodenticide ingestion in children. Abstract presented and the AACT/AAPCC/ABMT/CAPCC anual scientific meeting, Vancouver, B.C.Canada, September 27 – October 2, 1987
   Google Scholar
• Badr M., Yoshihara H., Kauffman F., Thurman R. A. Menadione causes selective toxicity to periportal regions of the liver lobule. Toxicology Letters 1987; 35: 241–246
   PubMed Web of Science ®Google Scholar
• Aquamephyton. Physicians desk reference, B. B. Huff. Liton, Oradell, NJ 1987; 1243
   Google Scholar